Prevention of hepatocellular carcinoma;Prävention des hepatozellulären karzinoms

Praxis

Volumn 91, Issue 35, 2002, Pages 1393-1395

  Von Weizsacker F ^a   Allgaier, H P ^a   Blum, H E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Chronic viral hepatitis; Hepatocellular carcinoma; Liver cirrhosis; Vaccine

Indexed keywords

ARTICLE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; RISK FACTORS;

EID: 0037190189     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.91.35.1393     Document Type: Review

References (8)

1. Allgaier H.P. (Hrsg.): Hepatozelluläres Karzinom. Uni Med Verlag Bremen, Boston, 2002.
2. Chung S.W., Toth J.L., Rezieg M., et al.: Liver transplantation for hepatocellular carcinoma. Am. J. Surg., 167: 317-321, 1994. (Pubitemid 24257984)
3. Chang M.H., Chen C.J., Lai M.S., et al.: Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N. Engl. J. Med., 336: 1855-1859, 1997.
4. Baumert T.F., Lechmann M., Linag TJ: Strategies in hepatitic C virus vaccine development In: Therapy in liver diseases, J Rodes, Hrsg stm medicina, Barcelona, im Druck.
5. Blum H.E., Moradpour D.: Chronic hepatitis. 2: Treatment. Dtsch. Med. Wochenschr., 126: 786-789, 2001.
6. Jaeckel E., Cornberg M., Wedemeyer H., et al.: Treatment of acute hepatitis C with interferon alfa-2b. N. Engl. J. Med. www.nejm.org (10.1056/NEJMoa011232), 2001.
7. Nishiguchi S., Shiomi S., Nakatani S., et al.: Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet, 357: 196-197, 2001. (Pubitemid 32108094)
8. Ueki T., Kaneda Y., Tsutsui H., et al.: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat. Med., 5: 226-230, 1999. (Pubitemid 29068532)